MX9706140A - Composiciones de aminoacidos y el uso de las mismas en nutricion clinica. - Google Patents

Composiciones de aminoacidos y el uso de las mismas en nutricion clinica.

Info

Publication number
MX9706140A
MX9706140A MX9706140A MX9706140A MX9706140A MX 9706140 A MX9706140 A MX 9706140A MX 9706140 A MX9706140 A MX 9706140A MX 9706140 A MX9706140 A MX 9706140A MX 9706140 A MX9706140 A MX 9706140A
Authority
MX
Mexico
Prior art keywords
tnf
amino acid
diminution
levels
acid compositions
Prior art date
Application number
MX9706140A
Other languages
English (en)
Other versions
MXPA97006140A (es
Inventor
Heinz Schneider
Ronald G Thurman
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08392694 external-priority patent/US5656608B1/en
Priority claimed from GBGB9512100.0A external-priority patent/GB9512100D0/en
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Publication of MX9706140A publication Critical patent/MX9706140A/es
Publication of MXPA97006140A publication Critical patent/MXPA97006140A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invencion proporciona el uso de al menos un aminoácido seleccionado del grupo que consiste de la glicina, alanina y serina, o las sales fisiologicamente aceptables de los mismos, en la preparacion de un medicamente o formulacion nutricional, para la disminucion de los niveles del factor de la necrosis en tumores (TNF) en pacientes en quienes esos niveles están elevados más allá de aquéllos que median la homeostasis fisiologica y la inflamacion local. Esa disminucion de los niveles del TNF se pueden lograr, inter alia, mediante la inhibicion o disminucion de: (i) la produccion del factor de la necrosis de tumores (TNF) por células del tipo macrofagos; (ii) la liberacion del TNF por células del tipo macrofagos; y/o (iii) el enlazamiento del TNF por receptores del TNF.
MXPA/A/1997/006140A 1995-02-23 1997-08-12 Composiciones de aminoacidos y el uso de las mismas en nutricion clinica MXPA97006140A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08392694 US5656608B1 (en) 1995-02-23 1995-02-23 Amino acid compositions and methods of treatment using same
US08392694 1995-02-23
GB9512100.0 1995-06-14
GBGB9512100.0A GB9512100D0 (en) 1995-06-14 1995-06-14 Improvements in or relating to organic compounds
PCT/EP1996/000739 WO1996025861A1 (en) 1995-02-23 1996-02-22 Amino acid compositions and use thereof in clinical nutrition

Publications (2)

Publication Number Publication Date
MX9706140A true MX9706140A (es) 1997-11-29
MXPA97006140A MXPA97006140A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
PT810829E (pt) 2000-08-31
PL321238A1 (en) 1997-11-24
FI972744A (fi) 1997-08-22
DE69607750T2 (de) 2000-08-31
DE69607750D1 (de) 2000-05-18
CA2210499A1 (en) 1996-08-29
JPH11501301A (ja) 1999-02-02
NO973884L (no) 1997-10-17
EP0810829B1 (en) 2000-04-12
ES2145997T3 (es) 2000-07-16
NO973884D0 (no) 1997-08-22
ATE191615T1 (de) 2000-04-15
PL182205B1 (pl) 2001-11-30
WO1996025861A1 (en) 1996-08-29
CN1175887A (zh) 1998-03-11
KR19980702436A (ko) 1998-07-15
AU710527B2 (en) 1999-09-23
DK0810829T3 (da) 2000-08-28
BR9607336A (pt) 1997-11-25
FI972744A0 (fi) 1997-06-25
HUP9800049A2 (hu) 1998-05-28
HUP9800049A3 (en) 1999-01-28
EP0810829A1 (en) 1997-12-10
CZ266797A3 (cs) 1998-03-18
AU4879596A (en) 1996-09-11

Similar Documents

Publication Publication Date Title
AU4879596A (en) Amino acid compositions and use thereof in clinical nutrition
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
BG103335A (en) Application of fumaric acid derivatives
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
IL112111A (en) Peptides having growth hormone releasing properties and pharmaceutical compositions containing them
EP0797999A3 (en) Formulations of obesity protein
MXPA02012064A (es) Complejos de farmaco macromoleculares y composiciones que los contienen.
UA66856C2 (uk) Тієнопіримідини, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
HK1030160A1 (en) Methods of enhancing functioning of the upper gastrointestinal tract
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
MY124560A (en) Amino acid compositions and use thereof in immunosuppression
WO2002058589A3 (en) Agents and methods for promoting bone growth
PL373795A1 (en) Thymosin alpha 1 peptide/polymer conjugates
Wildburger et al. Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro
WO2003049687A3 (en) Medicinal compositions & therapeutic methods
EP1285660A4 (en) ZINC SUPPLEMENTARY COMPOSITIONS FOR ORAL ADMINISTRATION
EP0855181A3 (en) Medicament or nutritional formulation for immune-modulation with amino acids
EP0821969A3 (en) Medicinal Composition comprising TCF-II
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
NZ336043A (en) Use of COMT inhibitors for preventing diabetic vascular dysfunctions or neuropathy
GB8804188D0 (en) Pharmaceutical compositions
HK1025560A1 (en) Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
Wang et al. Effects of arginine-devoid diets in chronically uremic rats
WO2001039725A3 (en) Drug preparations
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제